Marcellin, P.
698  results:
Search for persons X
?
2

Impact of controlled attenuation parameter on detecting fib..:

Karlas, T. ; Petroff, D. ; Sasso, M....
Alimentary Pharmacology & Therapeutics.  47 (2018)  7 - p. 989-1000 , 2018
 
?
 
?
4

Predictors of HBeAg loss and seroconversion by baseline cli..:

Lim, Y.-S. ; Shalimar ; MA, X....
Journal of Hepatology.  68 (2018)  - p. S523-S524 , 2018
 
?
6

The negative impact of HBV/HCV coinfection on cirrhosis and..:

Pol, S. ; Haour, G. ; Fontaine, H....
Alimentary Pharmacology & Therapeutics.  46 (2017)  11-12 - p. 1054-1060 , 2017
 
?
 
?
9

On-treatment decline in HBeAg level at week 24 predicts for..:

Wong, D. ; Littlejohn, M. ; Yuen, L....
Journal of Hepatology.  66 (2017)  1 - p. S259-S260 , 2017
 
?
10

HBeAg levels at week 24 predict response to 8 years of teno..:

Wong, D. ; Littlejohn, M. ; Yuen, L....
Alimentary Pharmacology & Therapeutics.  47 (2017)  1 - p. 114-122 , 2017
 
?
11

A phase 3 study comparing tenofovir alafenamide to tenofovi..:

Brunetto, M. ; Lim, Y.S. ; Gane, E....
Journal of Hepatology.  66 (2017)  1 - p. S25-S26 , 2017
 
?
12

HCV eradication reduces the occurrence of major adverse car..:

Cacoub, P. ; Nahon, P. ; Layese, R....
Journal of Hepatology.  66 (2017)  1 - p. S20-S21 , 2017
 
?
 
1-15